We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Mobile Smartphone Application Detects Atrial Fibrillation

By HospiMedica International staff writers
Posted on 28 Mar 2018
Print article
Image: A smartphone app can noninvasively detect AF (Photo courtesy of Hanna Oksanen/ UTU).
Image: A smartphone app can noninvasively detect AF (Photo courtesy of Hanna Oksanen/ UTU).
A new app uses the accelerometers and gyroscopes integrated into modern smartphones in order to detect cardiac activity and identify atrial fibrillation (AF).

Developed at the University of Turku (UTU; Finland) and Turku University Hospital (Finland), the smartphone mechanocardiography app uses the integrated accelerometer to detect three-dimensional (3D) linear motion, and the integrated gyroscope to detect 3D rotational motion along three axes. The app then uses proprietary algorithms to analyze the micromovements in the chest and reliably determine AF.

In a blind study conducted to validate the smartphone app, the researchers compared it to visual interpretation of telemetry electrocardiographic (ECG) recordings in 300 hospitalized patients. The results showed 96% accuracy in AF identification. According to the researchers, the results are also significant in that the study group included different kinds of patients, some of whom had heart failure (HF), coronary artery disease (CAD), and ventricular extrasystole at the same time. The study was published on March 11, 2018, in Circulation.

“This is the first time that ordinary consumer electronics have achieved such reliable results that they can be actually beneficial for the patient's medical care. The results are also remarkable in that intermittent atrial fibrillation is not always detected even at the doctor's office,” said senior author Professor Juhani Airaksinen, MD, of Turku University Hospital. “If everyone can measure with an ordinary smart phone whether they have atrial fibrillation, we have the possibility to direct patients straight to the doctor and further testing without any delay. Therefore, the potential for economic savings is significant.”

AF occurs when the heart's two upper chambers beat erratically. In one form, paroxysmal AF, patients have bouts of erratic beats that begin spontaneously and usually last less than a week. AF can lead to serious adverse events such as thrombi traveling from the heart to obstruct arteries supplying the brain, causing stroke, or other parts of the body causing tissue damage.

Related Links:
University of Turku
Turku University Hospital

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscope
EB-500

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Surgical Techniques

view channel
Image: NICO SPECTRA is only hand-held technology delivering blue light closer to target to enhance tissue fluorescence (Photo courtesy of NICO Corporation)

Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors

Grade III or IV gliomas are among the most common and deadly brain tumors, with around 20,000 cases annually in the U.S. and 1.2 million globally. These tumors are very aggressive and tend to infiltrate... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more